US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 685.660
  • +5.660+0.83%
Close Feb 19 16:00 ET
  • 685.660
  • 0.0000.00%
Post 20:01 ET
74.96BMarket Cap17.88P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Regeneron Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 4, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
3.75B
3.79B
+43.03M
Beat Est.
+9.08%
+10.33%
+1.15%
EPS
9.07
8.06
-1.01
Miss Est.
-10.99%
-20.90%
-11.14%
Buy

Feb 14, 2025

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.612B--
--2025/Q1-- / 3.430B--
Feb 4, 20252024/Q43.789B / 3.746B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.612B--
--2025/Q1-- / 3.430B--
Feb 4, 20252024/Q43.789B / 3.746B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More